SMTI
Sanara MedTech Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$34.75
+0.09%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 109.8M | 103.1M | 86.7M | 65.0M | 45.8M |
| Cost of Revenue | 9.5M | 10.2M | 8.1M | 7.9M | 6.4M |
| Gross Profit | 100.3M | 92.9M | 78.5M | 57.1M | 39.5M |
| Operating Expenses | |||||
| R&D Expense | 5.0M | 5.1M | 5.7M | 4.1M | 3.4M |
| SG&A Expense | 84.4M | 78.7M | 76.6M | 57.0M | 46.0M |
| General & Admin Expense | 22.6M | — | — | — | 46.0M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 619.1K | — | 3.0M | 225.1K | 2.7M |
| Total Operating Expenses | 90.0M | 83.8M | 85.2M | 61.4M | 52.0M |
| Cost and Expenses | 99.5M | 94.0M | 93.4M | 69.2M | 58.4M |
| Operating Income (EBIT) | 10.3M | 9.1M | (6.7M) | (4.2M) | (12.5M) |
| Non-Operating | |||||
| Interest Income | 66.8K | 3.7K | 22.0K | — | 284.7K |
| Interest Expense | 7.3M | 6.8M | 3.1M | 475.8K | 284.7K |
| Net Interest Income | (7.2M) | (6.8M) | (3.1M) | (475.8K) | — |
| Other Non-Op Income/Expense | (10.6M) | (9.5M) | (3.2M) | (224.7K) | (1.4M) |
| Non-Operating Income (excl Interest) | 3.3M | 2.8M | 68.0K | (251.0K) | 1.4M |
| EBT (Pre-Tax Income) | (286.3K) | (393.1K) | (9.9M) | (4.4M) | (13.9M) |
| Income Tax Expense | — | — | — | — | (5.8M) |
| Bottom Line | |||||
| Net Income | (32.0M) | (37.6M) | (9.7M) | (4.3M) | (7.9M) |
| Earnings from Cont. Ops | (286.3K) | (393.1K) | (9.9M) | (4.4M) | (8.1M) |
| Earnings from Discont. Ops | (31.7M) | (37.2M) | — | — | — |
| Bottom Line Net Income | (32.0M) | (37.6M) | (9.7M) | (4.3M) | (7.9M) |
| Per Share | |||||
| Basic EPS | ($3.72) | ($4.36) | ($1.14) | ($0.52) | ($1.00) |
| Diluted EPS | ($3.72) | ($4.36) | ($1.14) | ($0.52) | ($1.00) |
| Revenue Per Share | $12.68 | $11.96 | $10.22 | $7.85 | $5.80 |
| Shares | |||||
| Basic Shares Outstanding | 8.7M | 8.6M | 8.5M | 8.3M | 7.9M |
| Diluted Shares Outstanding | 8.7M | 8.6M | 8.5M | 8.3M | 7.9M |
| Profitability Metrics | |||||
| EBITDA | 9.5M | 9.0M | (1.9M) | (289.1K) | (11.6M) |
| D&A | 2.5M | 2.7M | 4.9M | 3.7M | 2.4M |
| EBIT | 7.0M | 6.4M | (6.8M) | (4.0M) | (13.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026